subscribeSubscribe
Enforcement Report for Week of August 7, 2024

Enforcement Report for Week of August 7, 2024
FDA
07 Aug 2024
Share Share
Enforcement Report - Week of July 5, 2023

Enforcement Report - Week of July 5, 2023
FDA
05 Jul 2023
Share Share
Health Canada Issues Recall of Ferring`s Endometrin effervescent vaginal tablets

Health Canada Issues Recall of Ferring`s Endometrin effervescent vaginal tablets
HEALTH CANADA
02 Jun 2023
Share Share
Enforcement Report - Week of February 1, 2023

Enforcement Report - Week of February 1, 2023
FDA
01 Feb 2023
Share Share
Utrogestan approved as HRT in Scotland

Utrogestan approved as HRT in Scotland
EUROPEANPHARMACEUTICALREVIEW
12 Dec 2022
Share Share
TherapeuticsMD Announces Second Quarter 2022 Financial Results

TherapeuticsMD Announces Second Quarter 2022 Financial Results
BUSINESSWIRE
15 Aug 2022
Share Share
Xiromed`s Generic Progesterone Receives Approval in the U.S.

Xiromed`s Generic Progesterone Receives Approval in the U.S.
FDA
05 Jan 2022
Share Share
Enforcement Report - Week of November 17, 2021

Enforcement Report - Week of November 17, 2021
FDA
17 Nov 2021
Share Share
Pfizer CenterOne’s Enviero® receives first EU authorization as part of ESTIMA® (progesterone) product approval.

Pfizer CenterOne’s Enviero® receives first EU authorization as part of ESTIMA® (progesterone) product approval.
M. Fassbender PRESS RELEASE
13 Nov 2021
Share Share
Theramex pioneers new treatment for post-menopausal women

Theramex pioneers new treatment for post-menopausal women
PHARMAFILE
24 Sep 2021
Share Share